Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
OnKure Therapeutics, Inc.
Market Cap
$99.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$101.36M
Net Profit Margin
6.49%
TTM Avg
-2.90%
3Y Avg
-6.49%
5Y Avg
0.99%
Market Cap
$97.14M
Net Profit Margin
-4477.08%
TTM Avg
-2757.42%
3Y Avg
-1378.71%
5Y Avg
-931.09%
Market Cap
$102.75M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1167.97%
5Y Avg
-1200.09%
Market Cap
$103.14M
Net Profit Margin
31.95%
TTM Avg
15.97%
3Y Avg
7.99%
5Y Avg
5.33%
Market Cap
$95.14M
Net Profit Margin
-3585.62%
TTM Avg
-2039.39%
3Y Avg
-2803.76%
5Y Avg
-1916.79%
Market Cap
$104.26M
Net Profit Margin
-72.28%
TTM Avg
-110.67%
3Y Avg
-76.27%
5Y Avg
-63.46%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $99.62M | 0.00% | 0.00% | 0.00% | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| The Joint Corp. (JYNT)vs › | $101.36M | 6.49% | -2.90% | -6.49% | 0.99% |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | -4477.08% | -2757.42% | -1378.71% | -931.09% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | 0.00% | 0.00% | -1167.97% | -1200.09% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | 31.95% | 15.97% | 7.99% | 5.33% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | -3585.62% | -2039.39% | -2803.76% | -1916.79% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -72.28% | -110.67% | -76.27% | -63.46% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
